Semin Respir Crit Care Med 2001; 22(4): 347-356
DOI: 10.1055/s-2001-17380
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

The Clinical Significance of Histopathologic Subgroups in Idiopathic Interstitial Pneumonia: Is Surgical Lung Biopsy Essential?

Harold R. Collard1 , Talmadge E. King Jr2
  • 1Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado
  • 2Division of Pulmonary and Critical Care Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California
Further Information

Publication History

Publication Date:
26 September 2001 (online)

ABSTRACT

For many years, the clinical entity of idiopathic interstitial pneumonia (IIP) has been a source of confusion for physicians. There has been much debate over the utility of subclassifying this condition histopathologically. It now appears that such classification is useful, and the most important distinction is the presence or absence of usual interstitial pneumonia (UIP). Unlike the other histopathologic subgroups, UIP has a grave prognosis and responds poorly to traditional therapies. To emphasize this clinical difference, the diagnosis of idiopathic pulmonary fibrosis (IPF), once used synonymously with IIP, is now reserved for only those patients with the histopathologic pattern of UIP. Although the gold standard for the diagnosis of IPF/UIP remains surgical lung biopsy, recent studies suggest that careful clinical and radiographic evaluation can identify IPF/UIP with a specificity of 90% or more. In the absence of a clear clinical diagnosis, we recommend pursuing surgical lung biopsy. Knowledge of the underlying histopathology will allow for more accurate prognosis, help guide therapy, and make possible the clinical investigation of novel therapeutic agents for patients with IIP.

REFERENCES

  • 1 King T EJ, Costabel U, Cordier J-F. Statement on Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the American College of Chest Physicians (ACCP) adopted by the ATS and ACCP Board of Directors and by the ERS Executive Committee.  Am J Respir Crit Care Med . 2000;  161(2 Pt 1) 646-664
  • 2 du Bois M R. Diffuse lung disease: an approach to management.  BMJ . 1994;  309 175-179
  • 3 Raghu G. Interstitial lung disease: a diagnostic approach: are CT scan and lung biopsy indicated in every patient?.  Am J Respir Crit Care Med . 1995;  151(3 Pt 1) 909-914
  • 4 Schwarz M I. Approach to the understanding, diagnosis, and management of interstitial lung disease. In: Schwarz, King TE Jr, eds. Interstitial Lung Disease 3rd ed. Hamilton, Ontario, Canada: BC Decker 1998: 3-30
  • 5 Michaelson J E, Aguayo S M, Roman J. Idiopathic pulmonary fibrosis: a practical approach for diagnosis and management.  Chest . 2000;  118(3) 788-794
  • 6 British Thoracic Society. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults.  Thorax . 1999;  54(Suppl 1) S1-S28
  • 7 Smith C M, Holbrook T. Utilization of the transbronchial biopsy (TBB) and open lung biopsy for tissue to establish the diagnosis of idiopathic pulmonary fibrosis: survey of the California Thoracic Society membership.  Am Rev Respir Dis . 1990;  141 A62
  • 8 Johnston I DA, Gomm S A, Kalra S, Woodcock A A, Evans C C, Hind C RK. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom.  Eur Respir J . 1993;  6 891-893
  • 9 Hamman L, Rich A. Acute diffuse interstitial fibrosis of the lung.  Bull Johns Hopkins Hosp . 1944;  74 177-212
  • 10 Liebow A A, Carrington D B. The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M, eds. Frontiers of Pulmonary Radiology New York: Grune & Stratteon 1969: 102-141
  • 11 Stack B HR, Choo-Kang Y FJ, Heard B H. The prognosis of cryptogenic fibrosing alveolitis.  Thorax . 1972;  27 535-542
  • 12 Scadding J G, Hinson K FW. Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs): corelation of histology at biopsy with prognosis.  Thorax . 1967;  22 291-304
  • 13 Patchefsky A S, Israel H L, Hoch W S, Gordon G. Desquamative interstitial pneumonia: relationship to interstitial fibrosis.  Thorax . 1973;  28 680-693
  • 14 Katzenstein A L, Myers J L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.  Am J Respir Crit Care Med . 1998;  157(4 Pt 1) 1301-1315
  • 15 Travis W D, King Jr E T, Bateman E D. ATS/ERS international multidisciplinary consensus classification of idiopathic interstitial pneumonias: general principles and recommendations.  Am J Respir Crit Care Med 2001 In press.
  • 16 Carrington C B, Gaensler E A, Coutu R E, FitzGerald M X, Gupta R G. Natural history and treated course of usual and desquamative interstitial pneumonia.  N Engl J Med . 1978;  298 801-809
  • 17 Bjoraker J A, Ryu J H, Edwin M K. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.  Am J Respir Crit Care Med . 1998;  157(1) 199-203
  • 18 Daniil Z D, Gilchrist F C, Nicholson A G. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.  Am J Respir Crit Care Med . 1999;  160(3) 899-905
  • 19 Yousem S A, Colby T V, Gaensler E A. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia.  Mayo Clin Proc . 1989;  64 1373-1380
  • 20 Wells A U, Cullinan P, Hansell D M. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.  Am J Respir Crit Care Med . 1994;  149 1583-1590
  • 21 Katzenstein A L, Fiorelli R F. Nonspecific interstitial pneumonia/fibrosis: histologic patterns and clinical significance.  Am J Surg Path . 1994;  18 136-147
  • 22 Myers J L, Veal Jr F C, Shin M S, Katzenstein A L. Respiratory bronchiolitis causing interstitial lung disease: a clinicopathologic study of six cases.  Am Rev Respir Dis . 1987;  135 880-884
  • 23 Nicholson A, Colby T V, du Bois M R, Hansell D M, Wells A U. The prognostic significance of the histologic pattern of interstitial pneumonia in patients with the clinical entity of cryptogenic fibrosing alveolitis.  Am J Respir Crit Care Med . 2000;  162 2213-2217
  • 24 Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby T V. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP.  European Respiratory Journal . 1998;  12 1010-1019
  • 25 Olsen J, Colby T V, Elliott C G. Hamman-Rich syndrome revisited.  Mayo Clin Proc . 1990;  65 1538-1548
  • 26 Tukiainen P, Taskinen E, Holsti P, Korhola O, Valle M. Prognosis of cryptogenic fibrosing alveolitis.  Thorax . 1983;  38 349-355
  • 27 Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.  Thorax . 1980;  35 593-599
  • 28 Mapel D W, Samet J M, Coultas D B. Corticosteroids and the treatment of idiopathic pulmonary fibrosis: past, present, and future.  Chest . 1996;  110(4) 1058-1067
  • 29 Gay S E, Kazerooni E A, Toews G B. Idiopathic pulmonary fibrosis: predicting response to therapy and survival.  Am J Respir Crit Care Med . 1998;  157(4 Pt 1) 1063-1072
  • 30 Douglas W W, Ryu J H, Swensen S J, for the Lung Study Group. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis: a randomized prospective study.  Am J Respir Crit Care Med . 1998;  158 220-225
  • 31 Douglas W W, Ryu J H, Schroeder D R. Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival.  American Journal of Respiratory and Critical Care Medicine . 2000;  161(4 Pt 1) 1172-1178
  • 32 Raghu G, Depaso W J, Cain K. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled trial.  Am Rev Respir Dis . 1991;  144 291-296
  • 33 Johnson M A, Snell N JC, Nunn A J, Darbyshire J H, Turner-Warwick M. Randomized controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.  Thorax . 1989;  44 280-288
  • 34 Zisman D A, Lynch III P J, Toews G B, Kazerooni E A, Flint A, Martinez F J. Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids.  Chest . 2000;  117(6) 1619-1626
  • 35 Raghu G, Johnson W C, Lockhart D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study.  Am J Respir Crit Care Med . 1999;  159(4 Pt 1) 1061-1069
  • 36 Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block L H. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis [see comments].  N Engl J Med . 1999;  341(17) 1264-1269
  • 37 Grenier P, Chevret S, Beigelman C, Brauner M, Chastang C, Valeyre D. Chronic Diffuse Infiltrative Lung Disease: Determination of the Diagnostic Value of Clinical Data, Chest Radiography, and CT with Bayesian Analysis.  Radiology . 1994;  191 383-90
  • 38 Drent M, Van Nierdop M F A, Gerritsen F A, Wouters E FM, Mulder P GH. A Computer Program Using BALF-Analysis Results as a Diagnostic Tool in Interstitial Lung Diseases.  Am J Respir Crit Care Med . 1996;  153 736-41
  • 39 Robinson P C, Watters L C, King Jr E T, Mason R J. Idiopathic pulmonary fibrosis: abnormalities in bronchoalveolar lavage fluid phospholipids.  Am Rev Respir Dis . 1988;  137 585-591
  • 40 Watters L C, Schwarz M I, Cherniack R M. Idiopathic pulmonary fibrosis: pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy.  Am Rev Respir Dis . 1987;  135 696-704
  • 41 BAL Cooperative Group. Bronchoalveolar lavage constituents in healthy individuals: idiopathic pulmonary fibrosis and selected comparison groups.  Am Rev Respir Dis . 1990;  141 S169-S202
  • 42 Haslam P L, Turton C WG, Heard B, Lukoszek J V, Salsbury A J, Turner-Warwick M. Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features.  Thorax . 1980;  35 9-18
  • 43 Burt M E, Flye M W, Webber B L, Wesley R A. Prospective evaluation of aspiration needle, cutting needle, transbronchial, and open lung biopsy in patients with pulmonary infiltrates.  Ann Thorac Surg . 1981;  32(2) 146-153
  • 44 Gilman M J, Wang K P. Transbronchial lung biopsy in Sarcoidosis.  Am Rev Respir Dis . 1980;  122 721-724
  • 45 Wall C P, Gaensler E A, Carrington C B, Hayes J A. Comparison of transbronchial and open biopsies in chronic infiltrative lung disease.  Am Rev Respir Dis . 1981;  123 280-285
  • 46 McLoud T C, Carrington C B, Gaensler E A. Diffuse infiltrative lung disease: a new scheme for description.  Radiology . 1983;  149 353-363
  • 47 Mathieson J R, Mayo J R, Staples C A, Muller N. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography.  Radiology . 1989;  171 111-116
  • 48 Epler G R, McLoud T C, Gaensler E A, Mikus J P, Carrington C B. Normal chest roengenograms in chronic diffuse infiltrative lung disease.  N Engl J Med . 1978;  298 934-939
  • 49 Liebow A A, Steer A, Billingsley J G. Desquamative interstitial pneumonia.  Am J Med . 1965;  39 369-404
  • 50 Winterbauer R H, Hammar S P, Hallman K O. Diffuse interstitial pneumonitis clinicopathologic correlations in 20 patients treated with prednizone/azathioprine.  Am J Med . 1978;  65 661-672
  • 51 Watters L C, King Jr E T, Schwarz M I, Waldron J, Stanford R E, Cherniack R M. A clinical, radiographic and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis.  Am Rev Respir Dis . 1986;  133 97-103
  • 52 Swensen S J, Aughenbaugh G L, Brown L R. High-resolution computed tomography of the lung.  Mayo Clin Proc . 1989;  64 1284-1294
  • 53 Felson B. A new look at pattern recognition of diffuse pulmonary disease.  AJR . 1979;  133 183-189
  • 54 Muller N, Miller R R, Webb R W, Evans K G, Ostrow D N. Fibrosing alveolitis: CT-pathologic correlation.  Radiology . 1986;  160 585-588
  • 55 Nishimura K, Kitaichi M, Izumi T, Nagai S, Kanaoka M, Itoh H. Usual interstitial pneumonia: histologic correlation with high-resolution CT.  Radiology . 1992;  182 337-342
  • 56 Orens J B, Kazerooni E A, Martinez F J. The sensitivity of high-resolution CT in detecting idiopathic pulmonary fibrosis proved by open lung biopsy: a prospective study.  Chest . 1995;  108(1) 109-115
  • 57 Remy-Jardin M, Giraud F, Remy J, Copin M C, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation.  Radiology . 1993;  189 693-698
  • 58 Nishimura K, Izumi T, Kitaichi M, Nagai S, Itoh H. The diagnostic accuracy of high-resolution computed tomography in diffuse infiltrative lung disease.  Chest . 1993;  104 1149-1155
  • 59 Padley S PG, Hansell D M, Flower C DR, Jennings P. Comparative accuracy of high-resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease.  Clinical Radiology . 1991;  44 222-226
  • 60 Tung K T, Wells A U, Rubens M B, Kirk J ME, du Bois M R, Hansell D M. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis.  Thorax . 1993;  48 334-338
  • 61 Lynch D A, Newell J D, King Jr E T, Muller N. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?.  AJR . 1995;  165(4) 807-811
  • 62 Hunninghake G W, Zimmerman M B, Schwartz D A, King Jr E T, Lynch III P J, Hegele R. Utility of lung biopsy for the diagnosis of idiopathic pulmonary fibrosis.  Am J Respir Crit Care Med . 2001;  164 193-196
  • 63 Johkoh T, Müller N L, Cartier Y. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients.  Radiology . 1999;  211(2) 555-560
  • 64 Raghu G, Mageto Y N, Lockhart D, Schmidt R A, Wood D E, Godwin J D. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study.  Chest . 1999;  116(5) 1168-1174
  • 65 Swensen S J, Aughenbaugh G L, Myers J L. Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung.  Radiology . 1997;  205(1) 229-234
  • 66 Gaensler E A, Carrington C B. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients.  Ann Thorac Surg . 1980;  30(5) 411-426
  • 67 Bensard D D, McIntyre Jr C R, Waring B J, Simon J S. Comparison of video thoracoscopic lung biopsy to open lung biopsy in the diagnosis of interstitial lung disease.  Chest . 1993;  103 765-770
  • 68 Ayed A K, Raghunathan R. Thoracoscopy versus open lung biopsy in the diagnosis of interstitial lung disease: a randomised controlled trial.  J R Coll Surg Edinb . 2000;  45(3) 159-163
  • 69 Boutin C, Viallat J R, Cargnino P, Rey F. Thoracoscopic lung biopsy: experimental and clinical preliminary study.  Chest . 1982;  82(1) 44-48
  • 70 Rena O, Casadio C, Leo F. Videothoracoscopic lung biopsy in the diagnosis of interstitial lung disease.  Eur J Cardiothor Surg . 1999;  16(6) 624-627
  • 71 Zegdi R, Azorin J, Tremblay B, Destable M D, Lajos P S, Valeyre D. Videothoracoscopic lung biopsy in diffuse infiltrative lung diseases: a 5-year surgical experience.  Ann Thorac Surg . 1998;  66(4) 1170-1173
  • 72 Krasna M J, White C S, Aisner S C, Templeton P A, McLaughlin J S. The role of thoracoscopy in the diagnosis of interstitial lung disease.  Ann Thorac Surg . 1995;  59(2) 348-351
  • 73 Hartman D Z, Mylet D, Gaither J G. Comparison of thoracoscopic lung biopsy with open lung biopsy in diffuse interstitial lung disorders.  Am Rev Respir Dis . 1992;  145 A750
  • 74 Carnochan F M, Walker W S, Cameron E W. Efficacy of video assisted thoracoscopic lung biopsy: an historical comparison with open lung biopsy.  Thorax . 1994;  49(4) 361-363
  • 75 Ferson P F, Landreneau R J, Dowling R D. Comparison of open versus thoracoscopic lung biopsy for diffuse infiltrative pulmonary disease.  J Thorac Cardiovasc Surg . 1993;  106(2) 194-199
  • 76 Miller J D, Urschel J D, Cox G. A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease.  Ann Thorac Surg . 2000;  70 1647
  • 77 Travis W D, Matsui K, Moss J, Ferrans V J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia.  Am J Surg Path . 2000;  24(1) 19-33